New Zealand: Agricultural Biotechnology Annual

  |   Attaché Report (GAIN)

Contact:

Office of Agricultural Affairs, Canberra   |   (011-61-2) 6214 5854

There have been no official changes to the heavily regulated and cautious policy settings operated by the New Zealand Government in relation to products derived from biotechnology. A genetic engineered (GE) equine influenza vaccine is the only GE product approved for use in New Zealand, and there have only been 21 contained field trials approved to operate.

New Zealand: Agricultural Biotechnology Annual

New Technologies
East Asia and the Pacific, New Zealand

Database Source:

Related Reports

View More
Attaché Report (GAIN)

Ukraine: Biotechnology and Other New Production Technologies Annual

The biotechnology regulatory system in Ukraine is still not fully developed, but the country is gradually adjusting its domestic policies to align with European Union regulations.
Attaché Report (GAIN)

Tunisia: Agricultural Biotechnology Annual

Tunisia is continuing to postpone non-urgent matters in front of major political and economic reforms. As a result, Tunisia’s biosafety framework, which was drafted in 2014, remains on hold with no timeframe for a review and parliamentary vote.
Attaché Report (GAIN)

Thailand: Rice Price - Weekly

Export prices of white and parboiled rice rose one percent from the previous week as exporters reportedly continued to secure the rice supplies to fulfill contract shipments.